
基本信息:
- 专利标题: Tubulin Mutation Diagnostic
- 专利标题(中):微管蛋白突变诊断
- 申请号:US11718957 申请日:2005-11-10
- 公开(公告)号:US20080131884A1 公开(公告)日:2008-06-05
- 发明人: Kenneth Wayne Culver , Markus Wartmann , Stan Lilleberg , Jian Zhu
- 申请人: Kenneth Wayne Culver , Markus Wartmann , Stan Lilleberg , Jian Zhu
- 优先权: GB0425038.7 20041112
- 国际申请: PCT/EP05/12044 WO 20051110
- 主分类号: A61K48/00
- IPC分类号: A61K48/00 ; A61P43/00 ; C07H21/04 ; C07K16/00 ; C12Q1/68 ; G01N33/53
摘要:
The present invention relates to methods for determining the potential of a subject to respond to a particular therapeutic agent, by determining the presence of one or more nucleotide or amino acid variants in the β-tubulin gene or protein. Also provided are methods for treating subjects whose potential to respond to a therapeutic agent has been evaluated. For use in the methods of the invention, there are provided variants of the β-tubulin gene, variants of the β-tubulin protein, nucleic acid molecules and agents which bind to the variant β-tubulin nucleic acid molecules and variant β-tubulin protein, respectively, and kits comprising the same.
摘要(中):
本发明涉及通过测定β-微管蛋白基因或蛋白质中一个或多个核苷酸或氨基酸变体的存在来确定受试者对特定治疗剂作出反应的潜力的方法。 还提供了用于治疗对治疗剂有响应的潜能的方法。 为了用于本发明的方法,提供β-微管蛋白基因的变体,β-微管蛋白的变体,结合变体β-微管蛋白核酸分子和变体β-微管蛋白的核酸分子和试剂 ,以及包含其的试剂盒。
IPC结构图谱:
A | 人类生活必需 |
--A61 | 医学或兽医学;卫生学 |
----A61K | 医用、牙科用或梳妆用的配制品 |
------A61K48/00 | 含有插入到活体细胞中的遗传物质以治疗遗传病的医药配制品;基因治疗 |